Sesen Bio Inc. [NASDAQ: SESN] stock went on an upward path that rose over 4.67% on Tuesday, amounting to a one-week price increase of more than 1.25%. The company report on November 7, 2022 that Sesen Bio Reports Third Quarter 2022 Financial Results and Business Update.
Sesen Bio announced proposed merger with Carisma Therapeutics.
Combined company will focus on the advancement of Carisma’s development of engineered macrophages for the treatment of cancer and other serious disorders.
Over the last 12 months, SESN stock dropped by -47.66%. The average equity rating for SESN stock is currently 3.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $114.62 million, with 200.46 million shares outstanding and 190.60 million shares in the current float. Compared to the average trading volume of 1.05M shares, SESN stock reached a trading volume of 4630239 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Sesen Bio Inc. [SESN]:
H.C. Wainwright have made an estimate for Sesen Bio Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on August 16, 2021. The new note on the price target was released on June 11, 2019, representing the official price target for Sesen Bio Inc. stock.
The Average True Range (ATR) for Sesen Bio Inc. is set at 0.04, with the Price to Sales ratio for SESN stock in the period of the last 12 months amounting to 1.91. The Price to Book ratio for the last quarter was 0.68, with the Price to Cash per share for the same quarter was set at 0.87.
SESN Stock Performance Analysis:
Sesen Bio Inc. [SESN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 1.25. With this latest performance, SESN shares gained by 1.49% in over the last four-week period, additionally sinking by -8.63% over the last 6 months – not to mention a drop of -47.66% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SESN stock in for the last two-week period is set at 56.56, with the RSI for the last a single of trading hit 59.14, and the three-weeks RSI is set at 53.53 for Sesen Bio Inc. [SESN]. The present Moving Average for the last 50 days of trading for this stock 0.5093, while it was recorded at 0.5424 for the last single week of trading, and 0.6105 for the last 200 days.
Insight into Sesen Bio Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Sesen Bio Inc. [SESN] shares currently have an operating margin of -106.09 and a Gross Margin at +99.68. Sesen Bio Inc.’s Net Margin is presently recorded at -1.27.
Return on Equity for this stock declined to -0.41, with Return on Assets sitting at -0.13.
Sesen Bio Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.50 and a Current Ratio set at 5.50.
Sesen Bio Inc. [SESN] Insider Position Details
There are presently around $15 million, or 12.90% of SESN stock, in the hands of institutional investors. The top three institutional holders of SESN stocks are: VANGUARD GROUP INC with ownership of 10,850,063, which is approximately 1.002% of the company’s market cap and around 0.10% of the total institutional ownership; BLACKROCK INC., holding 4,215,390 shares of the stock with an approximate value of $2.36 million in SESN stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $1.28 million in SESN stock with ownership of nearly -1.967% of the company’s market capitalization.
Positions in Sesen Bio Inc. stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 29 institutional holders increased their position in Sesen Bio Inc. [NASDAQ:SESN] by around 1,877,763 shares. Additionally, 30 investors decreased positions by around 5,616,644 shares, while 31 investors held positions by with 18,465,195 shares. The mentioned changes placed institutional holdings at 25,959,602 shares, according to the latest SEC report filing. SESN stock had 16 new institutional investments in for a total of 895,104 shares, while 16 institutional investors sold positions of 3,216,888 shares during the same period.